Plant extract composition for growing hair and preventing hair loss as well as preparation and application of plant extract composition

Through the combination of Maurozi and Hanlan extracts, the problem of plant extracts lacking anti-hair loss and hair growth effects in the prior art was solved, and the effect of significantly inhibiting the activity of type II 5α-reductase and promoting hair growth was achieved, satisfying the effect of satisfying the The market demand for anti-hair loss and hair growth products.

CN119015371APending Publication Date: 2024-11-26JIANGNAN UNIV
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411176038.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-26
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

There is a lack of plant extracts that can synergistically exert anti-hair loss and hair growth effects, have clear targets, and the mechanism of natural plant extracts to play unclear, making it difficult to develop anti-hair loss and hair growth products that meet market demand.

Method used

The composition of Maurozi extract and Hanlan extract is used, and the mass ratio is 0.5-5:0.5-5, and is extracted from water or aqueous ethanol to obtain a plant extraction composition for hair growth and anti-hair loss, using In preparation of shampoo, conditioner, scalp care products, etc.

Benefits of technology

It has achieved a higher inhibition of type II 5α-reductase activity, promoted the proliferation of dermal papillary cells and VEGF secretion, significantly improved hair growth, slowed down the process of hair loss, and developed effective products for androgen-derived hair loss.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005010740450000071
    Figure BDA0005010740450000071
  • Figure BDA0005010740450000091
    Figure BDA0005010740450000091
  • Figure BDA0005010740450000121
    Figure BDA0005010740450000121
Patent Text Reader

Abstract

The invention discloses a plant extract composition for growing hair and preventing hair loss as well as preparation and application thereof, and belongs to the field of application and development of cosmetics. The plant extract composition for growing hair and preventing hair loss is a composition of a fructus terminaliae billericae extract and a cymbidium kanran extract, and the mass ratio of fructus terminaliae billericae adopted in the fructus terminaliae billericae extract to cymbidium kanran adopted in the cymbidium kanran extract is (0.5-5): (0.5-5). By compounding the fructus terminaliae billericae and the cymbidium kanran for use, the enzyme activity of II type 5 alpha-reductase can be inhibited, an inhibitor aiming at the II type 5 alpha-reductase is developed, and the DHT level is reduced, so that the alopecia process is slowed down; the traditional Chinese medicine composition also can promote hair growth to cope with androgen-derived alopecia, promote secretion of VEGF, promote expression of a receptor VEGFR-2 of VEGF, activate VEGFR-2 to promote proliferation of dermal papilla cells, improve hair follicle activity and promote hair growth.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a plant extract composition for hair growth and hair loss prevention and a preparation method and application thereof, and belongs to the field of cosmetic application development. Background Art

[0002] With the continuous improvement of economic and technological levels, people's lives have become more diverse and faster, but the fast-paced, high-tech work and life have also brought unprecedented pressure to people. At present, the group of people with hair loss is constantly expanding, and the age is showing a downward trend. People born after 1990 have become the main force of hair loss, and hair loss is no longer just a "standard feature" for the middle-aged and elderly groups. The number of people who buy hair loss prevention and treatment products has gradually soared. Stimulated by market demand, there are more and more hair loss prevention products on the market, and the formulas used are also diverse. Compared with drugs such as minoxidil, natural medicinal plant ingredients are more concerned and favored by consumers, such as ginger, cypress leaves, Polygonum multiflorum, etc.

[0003] For example, CN113398042A discloses a Chinese medicine anti-hair loss shampoo, which mentions that the Chinese medicine composition in the Chinese medicine anti-hair loss shampoo includes Polygonum multiflorum, ginger, cypress leaves, perilla leaves, etc. The medicinal properties of each medicinal material complement each other and synergize, and it has significant effects of preventing hair loss, promoting hair growth, and strengthening hair;

[0004] CN115414424B discloses a phyllanthus emblica spray for preventing and treating hair loss and promoting hair growth and a preparation method thereof, wherein the solutes include phyllanthus emblica, terminalia chebula, terminalia chebula and the like, and the spray has the effects of preventing hair loss and promoting hair growth.

[0005] However, conventional plant extracts used to prevent hair loss have problems such as "many types of plant extracts, complex preparation, and unclear performance of individual plant extracts".

[0006] Moreover, there are many types of plants and the extracts have complex ingredients; it is impossible to simply select suitable plants from the plants to prepare plant extracts to meet the requirements of preventing hair loss and promoting hair growth.

[0007] In addition, there is no way to know how natural plant extracts can prevent hair loss and promote hair growth, and it is therefore impossible to infer the effects of some plant extracts that prevent hair loss and promote hair growth from the mechanism.

[0008] Therefore, developing a synergistic combination of plant extracts with significant anti-hair loss and hair growth effects and clear targets will help develop new anti-hair loss products to meet market demand. Summary of the invention

[0009] [Technical issues]

[0010] Currently, there is no literature mentioning plant extracts with clear targets that synergistically exert anti-hair loss and hair growth effects.

[0011] [Technical solution]

[0012] In order to solve the above problems, the present invention provides a plant extract composition for hair growth and hair loss prevention, which is a composition of a Terminalia chebula extract and a Cymbidium orchid extract. The present invention achieves better hair growth promotion and hair loss prevention effects by compounding the Terminalia chebula extract and the Cymbidium orchid extract.

[0013] The first object of the present invention is to provide a plant extract composition for hair growth and hair loss prevention, which is a composition of Terminalia chebula extract and Cymbidium orientale extract, wherein the mass ratio of Terminalia chebula used in the Terminalia chebula extract to Cymbidium orientale used in the Cymbidium orientale extract is 0.5-5:0.5-5.

[0014] As an embodiment of the present invention, the Terminalia chebula extract and the Cymbidium annuum extract are water extracts of Terminalia chebula and Cymbidium annuum respectively.

[0015] The second object of the present invention is to provide a method for preparing a plant extract composition for hair growth and hair loss prevention, comprising the following steps:

[0016] The terminalia chebula and cymbidium cymbidium are added into a solvent, and extracted at 50-100 DEG C for 2-6 hours to obtain a plant extract composition for hair growth and hair loss prevention.

[0017] As an embodiment of the present invention, the solvent is water or an ethanol aqueous solution.

[0018] As an embodiment of the present invention, the mass ratio of Terminalia chebula to Cymbidium orientalis is 0.5-5:0.5-5, more preferably 1-3:1-2, and even more preferably 1:1.

[0019] As an embodiment of the present invention, the ratio of the sum of the masses of Terminalia chebula and Cymbidium cymbidium to the solvent is 1-10 g: 10-100 mL.

[0020] As an embodiment of the present invention, after the extraction, the plant composition can be filtered, rotary evaporated, and freeze-dried to obtain a solid powder.

[0021] The third object of the present invention is the use of the hair growth and hair loss prevention plant extract composition of the present invention in the preparation of hair loss prevention products, hair growth products, and hair loss prevention and hair growth products.

[0022] As an embodiment of the present invention, the anti-hair loss product includes shampoo, conditioner, scalp care products and the like.

[0023] As one embodiment of the present invention, the anti-hair loss agent is used to treat androgenic alopecia.

[0024] As an embodiment of the present invention, the hair growth product includes shampoo, conditioner, scalp care products and the like.

[0025] As an embodiment of the present invention, the anti-hair loss and hair growth products include shampoo, conditioner, scalp care products and the like.

[0026] The fourth object of the present invention is to provide a shampoo for washing and protecting hair, which uses the plant extract composition for hair growth and preventing hair loss described in the present invention.

[0027] A fifth object of the present invention is to provide a hair conditioner, which uses the plant extract composition for hair growth and hair loss prevention of the present invention.

[0028] The sixth object of the present invention is to provide an anti-hair loss and hair growth essence, which uses the hair growth and anti-hair loss plant extract composition of the present invention.

[0029] The seventh object of the present invention is to provide a method for enhancing the activity of a product in inhibiting type II 5α-reductase, which uses the hair growth and hair loss prevention plant extract composition of the present invention.

[0030] As an embodiment of the present invention, inhibiting the activity of type II 5α-reductase includes reducing the production of dihydrotestosterone (DHT) by inhibiting the activity of type II 5α-reductase; and the product is used for treating androgenic alopecia.

[0031] As an embodiment of the present invention, the products include shampoo, conditioner, scalp care products and the like.

[0032] The eighth object of the present invention is to provide a method for enhancing the effect of a product in promoting the proliferation of dermal papilla cells, which uses the plant extract composition for hair growth and hair loss prevention described in the present invention.

[0033] As an embodiment of the present invention, the proliferation of dermal papilla cells is promoted by co-incubating dermal papilla cells with a plant extract composition for hair growth and hair loss prevention to activate potassium ion channels and promote cell proliferation.

[0034] As an embodiment of the present invention, the proliferation of dermal papilla cells is promoted by co-incubating dermal papilla cells with a plant extract composition for hair growth and hair loss prevention to promote the secretion of vascular endothelial growth factor (VEGF).

[0035] As an embodiment of the present invention, the products include shampoo, conditioner, scalp care products and the like.

[0036] The ninth object of the present invention is to provide a product for preventing hair loss based on inhibiting the activity of type II 5α-reductase, which uses the plant extract composition for hair growth and hair loss prevention of the present invention.

[0037] As an embodiment of the present invention, the products include shampoo, conditioner, scalp care products and the like.

[0038] The tenth object of the present invention is to provide a product for hair growth based on promoting the proliferation of dermal papilla cells, which uses the plant extract composition for hair growth and hair loss prevention of the present invention.

[0039] As an embodiment of the present invention, the products include shampoo, conditioner, scalp care products and the like.

[0040] [Beneficial Effects]

[0041] (1) The chebula extract used in the present invention has the effect of inhibiting the activity of type II 5α-reductase, while there is currently no public information on the effect of the Cymbidium extract on the activity of type II 5α-reductase; however, the two have a higher inhibitory effect on the activity of type II 5α-reductase by compounding. The inhibition rate of the chebula extract used in the present invention on the activity of type II 5α-reductase is 41%, the inhibition rate of the Cymbidium extract on the activity of type II 5α-reductase is 37%, and the inhibition rate of the compounded extract on the activity of type II 5α-reductase is 70%. The present invention inhibits the enzyme activity of type II 5α-reductase by compounding chebula and Cymbidium, develops an inhibitor for type II 5α-reductase, reduces the level of DHT, and thus slows down the process of hair loss.

[0042] (2) The chebula extract used in the present invention has the effect of promoting the proliferation of dermal papilla cells, while there is no public information on the effect of the Cymbidium extract on the proliferation of dermal papilla cells; however, after the two are combined, the ability to promote cell proliferation is significantly increased. The chebula extract disclosed in the present invention is used to incubate dermal papilla cells, and the cell proliferation is 22%; the Cymbidium extract is used to incubate dermal papilla cells, and the cell proliferation is 2%; the two are co-incubated with dermal papilla cells, and the cell proliferation is significantly increased by 45%.

[0043] (3) The present invention promotes hair growth to combat androgenic alopecia by using a combination of Terminalia chebula and Cymbidium orchioides, promotes the secretion of VEGF, promotes the expression of its receptor VEGFR-2, activates VEGFR-2 to promote the proliferation of dermal papilla cells, improves hair follicle activity, and promotes hair growth. DETAILED DESCRIPTION

[0044] The preferred embodiments of the present invention are described below. It should be understood that the embodiments are for better explaining the present invention and are not used to limit the present invention.

[0045] Yield test:

[0046] Weigh and record the mass of the initial plant material; after extraction, weigh the mass of the processed extract.

[0047] The calculation formula of yield is: yield = (mass of extract / mass of raw material) x 100%

[0048] The raw materials used in the examples are:

[0049] Terminalia chebula: fruit powder; 80 mesh;

[0050] Cold orchid: leaf powder; 80 mesh;

[0051] Patchouli: powder; 80 mesh;

[0052] Dried ginger: powder; 80 mesh.

[0053] In the examples and comparative examples, the solvents not specifically indicated are water, and the percentages not specifically indicated are percentages by mass;

[0054] Example 1

[0055] A method for preparing a plant extract composition for hair growth and hair loss prevention comprises the following steps:

[0056] 2.5 g of Terminalia chebula and 2.5 g of Cymbidium orientale were added into 50 mL of water, and the mixture was extracted at 100° C. for 4 h to obtain extracts of Terminalia chebula and Cymbidium orientale.

[0057] The extracts of Terminalia chebula and Cymbidium cymbidium were filtered, rotary evaporated and freeze-dried to obtain solid powder.

[0058] After weighing and calculation, the yield was 10.647 mg / g.

[0059] Example 2

[0060] A method for preparing a plant extract composition for hair growth and hair loss prevention comprises the following steps:

[0061] 0.5 g of Terminalia chebula and 0.5 g of Cymbidium orientale were added into 10 mL of water, and the mixture was extracted at 50° C. for 2 h to obtain extracts of Terminalia chebula and Cymbidium orientale.

[0062] The extracts of Terminalia chebula and Cymbidium cymbidium were filtered, rotary evaporated and freeze-dried to obtain solid powder.

[0063] After weighing and calculation, the yield was 4.091 mg / g.

[0064] Example 3

[0065] A method for preparing a plant extract composition for hair growth and hair loss prevention comprises the following steps:

[0066] 5 g of Terminalia chebula and 5 g of Cymbidium orientale were added into 100 mL of water, and the mixture was extracted at 100° C. for 6 h to obtain extracts of Terminalia chebula and Cymbidium orientale.

[0067] The extracts of Terminalia chebula and Cymbidium cyrtonema were filtered, rotary evaporated and freeze-dried to obtain solid powder. The yield was 21.672 mg / g after weighing and calculation.

[0068] Comparative Example 1

[0069] The cold orchid in Example 1 is omitted, and other conditions or parameters are consistent with those in Example 1;

[0070] The details are as follows:

[0071] 5 g of Terminalia chebula was added into 50 mL of water and extracted at 100° C. for 4 h to obtain a Terminalia chebula extract.

[0072] The chebula extract was filtered, rotary evaporated and freeze-dried to obtain a solid powder.

[0073] After weighing and calculation, the yield was 8.857 mg / g.

[0074] Comparative Example 2

[0075] The Terminalia chebula in Example 1 was omitted, and other conditions or parameters were the same as those in Example 1;

[0076] The details are as follows:

[0077] 5 g of Cymbidium orchid was added into 50 mL of water and extracted at 100° C. for 4 h to obtain Cymbidium orchid extract.

[0078] The Cymbidium orchid extract was filtered, rotary evaporated and freeze-dried to obtain a solid powder.

[0079] After weighing and calculation, the yield was 5.972 mg / g.

[0080] Comparative Example 3

[0081] The extraction solvent water in Example 1 was replaced with ethanol, and other conditions or parameters were consistent with those in Example 1;

[0082] The details are as follows:

[0083] 2.5 g of Terminalia chebula and 2.5 g of Cymbidium orientale were added into 50 mL of anhydrous ethanol, and the mixture was extracted at 50° C. for 4 h to obtain extracts of Terminalia chebula and Cymbidium orientale.

[0084] The extracts of Terminalia chebula and Cymbidium cyrtonema were filtered, rotary evaporated and freeze-dried to obtain solid powder. The yield was 5.362 mg / g after weighing and calculation.

[0085] Comparative Example 4

[0086] The cold orchid in Example 1 was adjusted to Guangmuxiang, and the other parts were kept consistent with Example 1 to obtain an extract.

[0087] Comparative Example 5

[0088] The chebula in Example 1 was adjusted to be another substance, dried ginger, and the rest was kept consistent with Example 1 to obtain an extract.

[0089] Example 4

[0090] The "2.5 g of Terminalia chebula and 2.5 g of Cymbidium orientale" in Example 1 was adjusted to "3 g of Terminalia chebula and 2 g of Cymbidium orientale", and the rest was kept consistent with Example 1, to obtain Terminalia chebula and Cymbidium orientale extracts.

[0091] The extracts of Terminalia chebula and Cymbidium cyrtonema were filtered, rotary evaporated and freeze-dried to obtain solid powder. The yield was 11.837 mg / g after weighing and calculation.

[0092] Example 5 Inhibition of Type II 5α-reductase Activity by Plant Extract Composition

[0093] (1) Test on the inhibitory activity of plant extract composition on type II 5α-reductase

[0094] The reaction system catalyzed by type II 5α-reductase in animals was simulated and a reaction system with a total volume of 1 mL was established.

[0095] Preparation of homogenate:

[0096] 0.34 mol / L sucrose solution: Accurately weigh 11.64 g of sucrose, dissolve it and make up to 100 mL.

[0097] 0.25 mol / L sucrose solution: Accurately weigh 8.56 g of sucrose, dissolve it and make up to 100 mL.

[0098] 100mmol / LPMSF stock solution: Accurately weigh 174mg PMSF, dissolve it in isopropanol, make up to 10mL, divide it into aliquots, and store at -20℃.

[0099] 100mmol / L DTT stock solution: Accurately weigh 154mg DTT, dissolve in sterile pure water, dilute to 10mL, divide into aliquots, and store at 4℃.

[0100] Homogenate: Use a pipette to precisely measure 100uL 100mM PMSF, 100uL 100mM DTT, and 1mL glycerol, dissolve in phosphate buffer (pH=5.5), and make up to 10mL.

[0101] The added amount of testosterone (T) was 50 μL, the added amount of phosphate buffer (pH = 5.5) was 300 μL, the added amount of 75% volume fraction ethanol aqueous solution was 50 μL, the added amount of type II 5α-reductase crude enzyme extract (concentration 1.35 mg / mL, sourced from SD rat epididymis (stripped fat tissue), added to the homogenate, and homogenized using a homogenizer) was 500 μL, the added amount of NADPH (99%, powder; source purchased from McLean) was 100 μL, and the added amount of the plant extract composition was 50 μL, as shown in Table 1.

[0102] Table 1 Experimental groups

[0103] Reagents Blank group Positive control group Plant extract composition 75% ethanol aqueous solution 50μL - - Phosphate buffered saline 300μL 300μL 300μL Testosterone T 50μL 50μL 50μL Type Ⅱ 5α-reductase crude enzyme extract 500μL 500μL 500μL NADPH 100μL 100μL 100μL Finasteride - 50μL - Plant extract composition - - 50μL

[0104] Note: “-” means that the solution is not added into the system.

[0105] Blank group: Testosterone (T), type II 5α-reductase crude enzyme extract, phosphate buffer, NADPH, and 75% ethanol aqueous solution were added to the reaction tube in sequence, and the absorbance A at 0 min was measured after mixing. 340nm After incubation at 37°C for 60 min, the absorbance A 340nm The absorbance decrease value (ΔA0) was obtained by deducting the NADPH blank decrease background value.

[0106] Plant extract composition group: testosterone (T), type II 5α-reductase crude enzyme extract, phosphate buffer, NADPH, and plant extract composition were added to the reaction tube in sequence, and the absorbance A at 0 min was measured after mixing. 340nm After incubation at 37°C for 60 min, the absorbance A 340nm The absorbance decrease value (ΔA n ).

[0107] Comparison of ΔA0 and ΔA n The value of the value was used to determine whether the activity of type II 5α-reductase was inhibited, and the formula I% = (ΔA0-ΔA n ) / ΔA0×100%, and preliminarily calculate the inhibition rate.

[0108] (2) Inhibitory effect of plant extract composition on type II 5α-reductase activity

[0109] Using finasteride as a positive control, the inhibition rates of the extracts prepared in Examples 1 to 4 and Comparative Examples 1 to 5 on the activity of type II 5α-reductase were tested; the inhibitory effects of various plant extracts on the activity of type II 5α-reductase are shown in Table 2;

[0110] From Table 2 we can see that:

[0111] The extracts of Terminalia chebula and Cymbidium cyrtonema in the examples have certain inhibitory activity on type II 5α-reductase. As the extraction time and extraction temperature increase, the inhibitory activity of the water extract on type II 5α-reductase increases.

[0112] The inhibition rate of the chebula extract of comparative example 1 on the activity of type II 5α-reductase was 41.64±2.75%; the inhibition rate of the Cymbidium cymbidium extract of comparative example 2 on the activity of type II 5α-reductase was 37.64±6.71%; the inhibition rate of the plant extract composition of Example 1 on the activity of type II 5α-reductase was 70.07±1.20%; that is, the combination of chebula extract and Cymbidium cymbidium extract had a synergistic effect on the inhibition of type II 5α-reductase activity;

[0113] The inhibitory capacity of the alcohol extract of comparative example 3 on type II 5α-reductase was significantly lower than that of the finasteride positive control group;

[0114] In Example 4, when the compound ratio of Terminalia chebula and Cymbidium orchid was changed, as the mass proportion of Terminalia chebula gradually increased, the inhibition rate of the compound extract on type II 5α-reductase activity was significantly lower than that in Example 1. When the mass ratio of Terminalia chebula and Cymbidium orchid was 1:1, the inhibition rate of the compound extract of Terminalia chebula and Cymbidium orchid on type II 5α-reductase activity was 70.07±1.20%, which was higher than that of the positive control group.

[0115] When Cymbidium and Terminalia chebula were compounded and extracted with other plants (Comparative Examples 4 and 5), the inhibition rates were lower than those of the finasteride positive control group.

[0116] Table 2 Inhibitory effect of plant extract composition on type II 5α-reductase activity

[0117]

[0118] Example 6 Plant extract composition promotes proliferation of dermal papilla cells

[0119] (1) Culture and subculture of dermal papilla cells

[0120] Take out the cryopreservation tube of dermal papilla cells stored in liquid nitrogen, shake it in a 37℃ water bath, and use a sterile pipette to quickly add it to DMEM high-glucose medium (containing 10% (v / v) fetal bovine serum and 1×10 5 U / L penicillin, 100mg / L streptomycin) in a T25 cell culture flask, shake well using the cross method, and place the flask in a cell culture incubator at 37°C, 5% CO2, and saturated humidity. After observing the cells adhere to the wall for 24 hours, change the medium and continue culturing.

[0121] When the cell density exceeds 80%, cell passaging:

[0122] Aspirate the culture medium, rinse twice with PBS by gently blowing, add trypsin containing 0.25% (w / v) EDTA (trypsin-EDTA (0.25%), containing phenol red, product number: 25200072, purchased from Gbico), digest for 3 minutes in the incubator, and terminate cell digestion with fresh DMEM complete culture medium.

[0123] The cell suspension was centrifuged at 1500 rpm for 5 min; fresh DMEM complete medium was added to blow the cell pellet, and the number of subculture bottles was determined according to the cell number, status and experimental requirements.

[0124] Place the culture flask in a cell culture incubator for culture.

[0125] (2) MTT method to determine the proliferation rate of dermal papilla cells

[0126] The cells in logarithmic growth phase were digested and counted on a hemocytometer.

[0127] 1×10 4 Cells were cultured in 96-well cell culture plates. After 24 hours of culture, the supernatant was discarded. Various plant extract composition solutions dissolved in culture medium were added to the sample wells at different concentrations. The concentration gradient was 100 μg / mL, 80 μg / mL, 50 μg / mL, 40 μg / mL, 20 μg / mL, 10 μg / mL, 5 μg / mL, 2.5 μg / mL, 1.25 ug / mL, and 0.625 ug / mL. No extract was used as the blank control group, and no cells and samples were used as the zero adjustment group. Multiple replicates were set for each well. After 24 hours of culture, the supernatant was discarded and washed with PBS. 100 μL of freshly prepared MTT (powder, purchased from McLean) solution of 0.5 mg / mL (dissolved in DEME culture medium) was added to each well. After incubation for 4 hours, the supernatant was discarded, 100 ul DMSO was added to each well to dissolve the crystals, and the solution was placed in an ELISA reader for 5 minutes of oscillation. The absorbance value was read at 490 nm on the ELISA reader. The cell proliferation calculation formula is as follows:

[0128] Cell proliferation rate (%) = [(A1-A0) / (A2-A0)] × 100%

[0129] Wherein: A0 represents the absorbance value of the solvent group; A1 represents the absorbance value of the sample group; A2 represents the absorbance value of the blank control group.

[0130] (3) Effect of plant extract composition on promoting proliferation of dermal papilla cells

[0131] Minoxidil was used as a positive control to detect whether the plant extract compositions of Examples 1 to 4 and Comparative Examples 1 to 5 could promote the proliferation of dermal papilla cells.

[0132] The test results are shown in Table 3.

[0133] It can be seen from Table 3 that among the maximum cell proliferation rates achieved when the extracts at different concentrations stimulated human dermal papilla cells, the compound extract of Terminalia chebula and Cymbidium orchid had the highest proliferation rate, and the Terminalia chebula extract also had the effect of promoting cell proliferation, which was significantly higher than that of the Cymbidium orchid extract group and the positive control group. This suggests that the compound extract of Terminalia chebula and Cymbidium orchid has the effect of promoting the proliferation of dermal papilla cells and promoting hair growth.

[0134] Moreover, at the same concentration, the effect of improving the cell proliferation rate of the Terminalia chebula extract of Comparative Example 1 and the Cymbidium orchid extract of Comparative Example 2 is much smaller than that of the plant extract composition of Example 1; that is, the combination of Terminalia chebula and Cymbidium orchid extract has a synergistic effect in promoting the proliferation of dermal papilla cells.

[0135] Table 3 Effect of plant extract composition on promoting proliferation of dermal papilla cells

[0136]

[0137] Example 7 Effect of plant extract composition on potassium ion channels

[0138] (1) Changes in potassium channels in dermal papilla cells

[0139] The cell culture method is the same as that in Example 5. (1) Cultivation and passage of dermal papilla cells:

[0140] The cells were seeded in 96-well cell culture plates at a cell density of 1 × 10 4 cells. After the cell culture plate was placed in a cell culture incubator for 24 hours (the cells adhered to the wall and grew to a density of 70-90%), the culture medium was aspirated, the bottom of the plate was rinsed twice with PBS, and different concentrations of tolbutamide (the concentration of tolbutamide was 0.0625 mg / mL, 0.1 mg / mL, 0.125 mg / mL, 0.2 mg / mL, 0.25 mg / mL, 0.4 mg / mL, 0.5 mg / mL, 0.6 mg / mL, 0.8 mg / ml, 1 mg / mL) dissolved in the culture medium were added, the culture medium was used as the blank control group, and the cell-free and culture medium-free group was used as the zero adjustment group. Multiple replicate wells were set for each concentration. After 24 hours of culture, the supernatant was discarded and washed with PBS, and 100 μL of freshly prepared MTT solution of 0.5 mg / mL (dissolved in DMEM culture medium) was added to each well. After incubation at 37°C in a carbon dioxide incubator for 4 h, the supernatant was discarded, 100 μL DMSO was added to each well to dissolve the crystals, the wavelength was set to 490 nm in the microplate reader, the absorbance was read after shaking for 5 min, and the cell proliferation rate was calculated.

[0141] According to the above cell viability test, the tolbutamide stimulation concentration corresponding to a cell proliferation rate of 60%-65% is selected as the appropriate tolbutamide stimulation concentration, and the dermal papilla cells are stimulated with appropriate tolbutamide to perform potassium ion channel test.

[0142] Cell culture method Example 5 (1) dermal papilla cell culture and passaging:

[0143] The cells were seeded in a 96-well cell culture plate, and the number of cells plated was 1×10 4 After the cell culture plate was placed in a cell culture incubator for 24 hours (cells adhered to the wall and grew to a density of 70-90%), the culture medium was removed, the bottom of the plate was rinsed twice with PBS, and 100 μL of freshly prepared potassium ion antagonist tolbutamide of appropriate concentration was added to each well. After incubation for 4 hours, the supernatant was discarded, and various plant extract composition solutions dissolved in freshly prepared DMEM high-glucose medium (specific components include glucose, L-glutamine, phenol red, sodium bicarbonate, amino acids, vitamins, and inorganic salts) were added. The concentrations of the plant extract compositions were set to 100 μg / mL, 80 μg / mL, 50 μg / mL, 40 μg / mL, 20 μg / mL, 10 μg / mL, 5 μg / mL, 2.5 μg / mL, 1.25 ug / mL, and 0.625 ug / mL, respectively; a blank group, a negative control group, and a minoxidil positive control group were set, and multiple replicates were set for each group. After culturing for 24 hours, the supernatant was discarded and washed with PBS, and 100 μL of freshly prepared MTT solution of 0.5 mg / mL (dissolved in DMEM medium) was added to each well. After incubation at 37°C in a carbon dioxide incubator for 4 hours, the supernatant was discarded, 100 ul of DMSO was added to each well to dissolve the crystals, the wavelength was set to 490 nm in the microplate reader, the absorbance was read after shaking for 5 minutes, and the cell proliferation rate was calculated.

[0144] (2) Effects of plant extract composition on potassium channels of dermal papilla cells

[0145] Table 4 shows the effects of the plant extract compositions prepared in Examples 1 to 4 and Comparative Examples 1 to 5 on potassium channels of dermal papilla cells.

[0146] Table 4 Effects of plant extract composition on potassium ion channels

[0147] Group Added drugs Effective concentration (ug / mL) Cell proliferation rate (%) Blank group - - 100 Negative control group Tolbutamide stimulation 1 62.29±4.05 Positive control group After tolbutamide stimulation, minoxidil incubation 5 88.79±6.82 Comparative Example 1 Tolbutamide stimulation, incubation with Terminalia chebula extract 40 75.62±4.07 Comparative Example 2 Tolbutamide stimulation, incubation with Cymbidium cymbidium extract 20 69.87±4.71 Comparative Example 3 Tolbutamide stimulation, alcohol extract incubation 20 64.79±3.21 Comparative Example 4 Tolbutamide stimulation, incubation with extracts of Terminalia chebula and Aucklandia lappa 40 60.29±1.23 Comparative Example 5 Tolbutamide stimulation, incubation with dried ginger and cold orchid extract 50 61.41±4.31 Example 1 Tolbutamide stimulation, incubation with the extract of Example 1 40 88.51±4.35 Example 2 Tolbutamide stimulation, incubation with the extract from Example 2 20 75.34±2.81 Example 3 Tolbutamide stimulation, incubation with the extract of Example 3 40 82.67±3.90 Example 4 Tolbutamide stimulation, incubation with the extract of Example 4 50 80.12±1.53

[0148] Note: “-” means that the solution is not added into the system.

[0149] As shown in Table 4, the extract of Terminalia chebula, the extract of Cymbidium orchid and the combination of Terminalia chebula and Cymbidium orchid can all restore the viability of cells stimulated by tolbutamide. Minoxidil can restore the viability of cells stimulated by tolbutamide from 62% to 88%, the extract of Terminalia chebula can restore the viability of cells stimulated by tolbutamide from 62% to 75%, the extract of Cymbidium orchid can restore the viability of cells stimulated by tolbutamide from 62% to 69%, and the combined extract of Terminalia chebula and Cymbidium orchid can restore the viability of cells stimulated by tolbutamide from 62% to 88%, which has a similar effect to minoxidil.

[0150] Potassium ion channels play a key role in mitosis through a variety of mechanisms, including participating in cell signal transduction, determining cell excitability and conductivity, affecting cell proliferation and apoptosis, etc. The opening and closing of potassium ion channels can affect cell proliferation and apoptosis signals, thereby affecting the regulation of the cell cycle. Minoxidil is a commonly used drug for the treatment of hair loss, and one of its mechanisms of action is to promote hair growth by opening potassium ion channels.

[0151] The above results indicate that the combination of Terminalia chebula and Cymbidium camphora can promote the opening of potassium ion channels to the greatest extent to affect cell proliferation.

[0152] Example 8 Effect of plant extract composition on VEGF secretion of dermal papilla cells

[0153] (1) Detection of vascular endothelial growth factor in dermal papilla cells

[0154] The cell culture method is the same as that in Example 5. (1) Cultivation and passage of dermal papilla cells:

[0155] The cells were seeded in 6-well cell culture plates at a cell density of 15 × 10 4 / mL. Place the cell culture plate in a cell culture incubator and culture for 24 hours (cells adhere to the wall and grow to a density of 70-90%), remove the culture medium, and rinse the bottom of the plate twice with PBS. Add 2mL of each plant extract composition solution freshly prepared and dissolved in the culture medium to each well, and the concentrations of each plant extract composition solution are set to 5, 10, and 20ug / ml respectively;

[0156] A blank group, a minoxidil positive control group, and a sample group with different concentrations were set up and cultured for 24 hours. The concentration of vascular endothelial growth factor in the culture medium was determined according to the ELISA kit operating instructions.

[0157] (2) Effect of plant extract composition on VEGF secretion in dermal papilla cells

[0158] The role and expression of vascular endothelial growth factor (VEGF) in dermal papilla cells are of great significance in hair growth and hair follicle development. During the growth phase, the formation of blood vessels around the hair follicle increases significantly, while the angiogenic vessels regress during the catagen and telogen phases. Transgenic overexpression of VEGF can induce vascularization around the hair follicle, accelerate hair regeneration, and increase the size of the hair follicle and hair shaft. VEGF induces the proliferation of human hair follicle dermal papilla cells through VEGFR-2-mediated EPK activation. Minoxidil stimulates angiogenesis by upregulating the expression of VEGF and its receptors, which may be one of the mechanisms by which it promotes the entry of hair follicles into the growth phase and promotes hair growth.

[0159] As shown in Table 5, minoxidil was used as the positive control group to detect the effects of the Terminalia chebula extract and the Cymbidium camphora extract on VEGF secretion at different concentrations.

[0160] As shown in Table 5, the secretion of VEGF is positively correlated with the concentration of each extract. The compound extract of Terminalia chebula and Cymbidium orchid promoted the secretion of VEGF the most, which was significantly higher than the minoxidil positive control group. The above results show that Terminalia chebula extract has the ability to promote the secretion of VEGF. The compound use of Terminalia chebula and Cymbidium orchid extract can make more VEGF secreted, which has the potential to promote hair growth.

[0161] Table 5 Effect of plant extract composition on VEGF secretion of dermal papilla cells

[0162]

[0163] In summary, the Terminalia chebula extract itself has the ability to promote cell proliferation and inhibit the activity of type II 5α-reductase. It can promote the secretion of VEGF, open potassium ion channels, and promote hair follicles to enter the growth phase to achieve the effect of promoting hair growth. The combined use of Cymbidium and Terminalia chebula extract can further promote the above-mentioned effects, promote hair growth, and achieve the effect of preventing hair loss.

[0164] Although the present invention has been disclosed as above in terms of preferred embodiments, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be defined by the claims.

Claims

1. A plant extract composition for hair growth and hair loss prevention, characterized in that: The invention is a composition of a terminalia chebula extract and a cymbidium cymbidium extract, wherein the mass ratio of the terminalia chebula used in the terminalia chebula extract to the cymbidium cymbidium used in the cymbidium cymbidium extract is 0.5-5:0.5-5.

2. A method for preparing the plant extract composition for hair growth and hair loss prevention according to claim 1, characterized in that: The steps include: The terminalia chebula and cymbidium cymbidium are added into a solvent, and extracted at 50-100 DEG C for 2-6 hours to obtain a plant extract composition for hair growth and hair loss prevention.

3. Use of the hair growth and anti-hair loss plant extract composition according to claim 1 in the preparation of anti-hair loss products, hair growth products, and anti-hair loss and hair growth products.

4. A shampoo for washing and conditioning hair, characterized in that: The plant extract composition for hair growth and hair loss prevention as claimed in claim 1 is used.

5. A hair conditioner, characterized in that The plant extract composition for hair growth and hair loss prevention as claimed in claim 1 is used.

6. An anti-hair loss and hair growth essence, characterized in that: The plant extract composition for hair growth and hair loss prevention as claimed in claim 1 is used.

7. A method for improving the activity of a product in inhibiting type II 5α-reductase, characterized in that: The plant extract composition for hair growth and hair loss prevention as claimed in claim 1 is used.

8. A method for enhancing the effect of a product on promoting the proliferation of dermal papilla cells, characterized in that: The plant extract composition for hair growth and hair loss prevention as claimed in claim 1 is used.

9. A product for preventing hair loss based on inhibiting the activity of type II 5α-reductase, characterized in that: The plant extract composition for hair growth and hair loss prevention as claimed in claim 1 is used.

10. A product for promoting hair growth by promoting the proliferation of dermal papilla cells, characterized in that: The plant extract composition for hair growth and hair loss prevention as claimed in claim 1 is used.

Citation Information

Patent Citations

  • Hair growth and fostering agent

    US20130302450A1